OTC Athlete’s Foot Drugs Scheduled For FDA Advisory Committee Review
This article was originally published in The Tan Sheet
Executive Summary
FDA's Nonprescription Drugs and Dermatologic & Ophthalmic Drugs advisory committees are scheduled to review OTCs used in treatment of interdigital tinea pedis at a May 6-7 meeting in Rockville, Md